CRVS CORVUS PHARMACEUTICALS INC
2026Q1 · CUSIP 221015100 · Sector: Healthcare & Biotech
Lit · Institutions accelerating in
Holders
163
Δ holders QoQ
+39
Breadth percentile
Top 6%
Whale holders
77
Δ whales
+15
Inst. holding value
$1.0B
New positions
68
Closed positions
29
Price momentum (1Q)
-30.2%
Put / Call
3/6
Breadth history (34 quarters)
Past Lit Events & Aftermath 4 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2026Q1 | Top 6% | — | — |
| 2023Q2 | Top 15% | — | — |
| 2021Q3 | Top 17% | -43.9% | -70.6% |
| 2020Q1 | Top 15% | — | — |
Options Sentiment
Put holders
3
QoQ: -2
Call holders
6
QoQ: +2
See methodology →
Fundamentals
PE (TTM)
—
EPS (TTM)
$-0.55
EPS YoY
—
Revenue (TTM)
—
Revenue YoY
—
Net margin
—
ROE
-18.4%
Debt ratio
4.9%
FCF (TTM)
-$35M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
As of 2026-03-31 · SEC filings (XBRL)
Get the next update
2026Q2 holdings publish around Aug 15 — subscribe to receive the lists first.